| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.61▼ | 1.62▼ | 1.62▼ | 1.58▲ | 1.44▲ |
| MA10 | 1.62▼ | 1.63▼ | 1.61▲ | 1.51▲ | 1.35▲ |
| MA20 | 1.60▲ | 1.59▲ | 1.58▲ | 1.41▲ | 1.47▲ |
| MA50 | 1.55▲ | 1.52▲ | 1.51▲ | 1.35▲ | 1.86▼ |
| MA100 | 1.51▲ | 1.44▲ | 1.39▲ | 1.51▲ | 2.14▼ |
| MA200 | 1.41▲ | 1.36▲ | 1.33▲ | 1.79▼ | 3.75▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | -0.003▼ | -0.001▼ | 0.026▲ | 0.045▲ |
| RSI | 54.956▲ | 56.831▲ | 58.362▲ | 66.713▲ | 50.711▲ |
| STOCH | 56.912 | 83.333▲ | 79.330 | 88.508▲ | 58.496 |
| WILL %R | -35.294 | -35.294 | -25.000▲ | -11.212▲ | -14.500▲ |
| CCI | -26.905 | 5.966 | 43.875 | 112.630▲ | 88.907 |
| ▼ RSI | $CLLS RSI(14) Crossed Below 70 | Set Alert |
|
Monday, April 28, 2025 01:30 PM
Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, ...
|
|
Monday, April 28, 2025 06:30 AM
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing ...
|
|
Thursday, April 24, 2025 05:00 PM
NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 1.65 | 1.65 | 1.4908 | 1.613 | 78,184 |
| 30/04/25 | 1.57 | 1.65 | 1.56 | 1.645 | 44,713 |
| 29/04/25 | 1.52 | 1.59 | 1.52 | 1.58 | 18,615 |
| 28/04/25 | 1.54 | 1.57 | 1.505 | 1.54 | 61,845 |
| 25/04/25 | 1.51 | 1.56 | 1.48 | 1.53 | 81,346 |
| 24/04/25 | 1.46 | 1.51 | 1.46 | 1.51 | 32,612 |
| 23/04/25 | 1.4513 | 1.48 | 1.425 | 1.46 | 59,440 |
| 22/04/25 | 1.38 | 1.46 | 1.37 | 1.44 | 44,580 |
| 21/04/25 | 1.43 | 1.44 | 1.36 | 1.38 | 25,869 |
| 17/04/25 | 1.44 | 1.4599 | 1.42 | 1.45 | 36,075 |
|
|
||||
|
|
||||
|
|